Rosalind Advisors, Inc. - 31 Dec 2025 SCHEDULE 13G/A Report for FENNEC PHARMACEUTICALS INC. Common Shares (FENC)

Filing Manager
Rosalind Advisors, Inc.
Reporting Manager
Rosalind Advisors, Inc.
Security
FENNEC PHARMACEUTICALS INC. Common Shares
Symbol
FENC
Shares outstanding
28,028,980 shares
Disclosed Ownership
2,746,840 shares
Ownership
9.8%
Form type
SCHEDULE 13G/A
Filing time
11 Feb 2026, 13:58:32 UTC
Date of event
31 Dec 2025
Previous filing
13 Nov 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Rosalind Advisors, Inc. disclosed 9.8% ownership in FENNEC PHARMACEUTICALS INC. Common Shares (FENC) on 31 Dec 2025."

Quick Takeaways

  • Rosalind Advisors, Inc. filed SCHEDULE 13G/A for FENNEC PHARMACEUTICALS INC. Common Shares (FENC).
  • Disclosed ownership: 9.8%.
  • Date of event: 31 Dec 2025.

What Changed

  • Previous schedule filing date: 13 Nov 2025.
  • Current filing was accepted on 11 Feb 2026, 13:58.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Rosalind Advisors, Inc. 9.8% 2,746,840 2,746,840 Steven Salamon President
SALAMON STEVEN A J 9.5% 2,680,174 66,666 2,613,508 Steven Salamon Steven Salamon
Aharon Gil 9.5% 2,680,174 66,666 2,613,508 Aharon Gil Aharon Gil
Rosalind Master Fund L.P. 9.3% 2,613,508 2,613,508 Mike McDonald Director, Rosalind (Cayman) Ltd. (as General Partner to Rosalind Master Fund)

Sponsored